Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-29

Clinical Trial Update: The Role of Melatonin as an Adjuvant Therapy in Childhood Pneumonia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating melatonin as an adjuvant therapy for pneumonia in children, currently in the recruitment stage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Mian Muhammad Hassan Ahmed | Conditions: Pneumonia Childhood | Phase 1, Phase 2 | Status: RECRUITING